newsfilter
← Latest News
Business Wire·

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present at the 14th C1 Inhibitor